![]() |
![]() |
|||||||||||||
|
Why SBS may need specialized treatment Living with Zorbtive is the latest treatment advance
|
Everyone diagnosed with Short Bowel Syndrome must learn to “live” with a surgically shortened or damaged small intestine.
What defines SBS |
|||||||||||||
|
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed. Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications. This information is not intended to replace discussions with your healthcare professional.
This Web site was developed by EMD
Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS
patients This site contains medical information that is intended for residents of the United States © 2007 EMD Serono, Inc. All rights reserved.
|
||||||||||||||